|1.||Amagase, Kikuko: 2 articles (10/2007 - 09/2007)|
|2.||Kato, Shinichi: 2 articles (10/2007 - 09/2007)|
|3.||Takeuchi, Koji: 2 articles (10/2007 - 09/2007)|
|4.||Tanaka, Akiko: 2 articles (10/2007 - 09/2007)|
|5.||Hatazawa, Ryo: 1 article (10/2007)|
|6.||Ashida, Yasuko: 1 article (10/2007)|
|7.||Tanigami, Mayu: 1 article (10/2007)|
|8.||Aihara, Eitaro: 1 article (09/2007)|
|2.||Stomach Ulcer (Gastric Ulcer)
09/01/2007 - "These results suggest that CJ-42794 does not cause any damage in the normal rat gastrointestinal mucosa and in the arthritic rat stomach and does not worsen the gastric ulcerogenic response to stress or aspirin in normal rats, although this agent slightly damages the small intestine of arthritic rats and impairs the healing of gastric ulcers."
09/01/2007 - "The repeated administration of CJ-42794 and rofecoxib as well as indomethacin impaired the healing of chronic gastric ulcers with a down-regulation of vascular endothelial growth factor expression in the ulcerated mucosa. "
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|3.||Aspirin (Acetylsalicylic Acid)